Compare TRX & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRX | NAUT |
|---|---|---|
| Founded | 1990 | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.0M | 383.5M |
| IPO Year | 2002 | 2020 |
| Metric | TRX | NAUT |
|---|---|---|
| Price | $1.56 | $3.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $1.70 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 4.3M | 347.2K |
| Earning Date | 04-14-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $73.52 | N/A |
| Revenue Next Year | $109.74 | $992.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.27 | $0.62 |
| 52 Week High | $2.80 | $4.31 |
| Indicator | TRX | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 52.64 | 58.50 |
| Support Level | $1.42 | $1.93 |
| Resistance Level | $1.95 | $4.31 |
| Average True Range (ATR) | 0.12 | 0.40 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 65.90 | 59.52 |
TRX Gold Corp is engaged in the exploration, development, and production of mineral property interests in the United Republic of Tanzania, focused on development and mining operations, and on exploring and evaluating its mineral properties. The business of exploring and mining for minerals involves a high degree of risk, and the underlying value of the mineral properties depends on the existence and economic recovery of mineral resources and reserves, as well as the ability to raise long-term financing to continue development. The company is focused on the Buckreef Gold Project, which comprises five prospects: Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba, and includes three main mineralized zones: Buckreef South, Buckreef Main, and Buckreef North.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.